Dysfuntional antigen presenting cell responses to influenza in geriatric individu
Dysfuntional antigen presenting cell responses to influenza in geriatric individu
批准号:
7484126
负责人:
DAVID H CANADAY
金额:
$18.95万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-15 至 2010-07-31
关键词:
AdjuvantAffectAgeAgingAntibodiesAntibody FormationAntigen PresentationAntigen Presentation PathwayAntigen-Presenting CellsAntigensAvian InfluenzaB-Cell ActivationB-LymphocytesBacterial InfectionsCD4 Positive T LymphocytesCell physiologyCellsCellular ImmunityCessation of lifeDataDefectDendritic CellsDepressed moodDifferentiation and GrowthDoseElderlyEngineeringGenerationsGenetic EngineeringGeriatricsHLA-DR AntigensHelper-Inducer T-LymphocyteHemagglutininHomingHumanHybridomasImmune responseImmunityImmunoglobulin AInactivated VaccinesIndividualInfluenzaInterferon-alphaInterleukin-12LeadLifeLiteratureMHC Class II GenesMyelogenousNational Institute of Allergy and Infectious DiseaseNeuraminidasePatternPersonsPredispositionPreparationProcessProductionPublic HealthSignal TransductionT-LymphocyteTransgenic MiceVaccinationVaccine AdjuvantVaccine DesignVaccinesViralage relatedagedchemokinecytokinedesignimmune functioninfluenza outbreakinfluenza virus vaccinemucosal vaccinepandemic influenzapathogenpreventresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): With recent advances in genetic engineering there is concern that pandemic influenza or avian influenza might emerge as a bioterror agent. In addition, the majority of deaths (90%) attributed to influenza are in persons age 65 or older. Elderly individuals have suboptimal responses to current influenza vaccine preparations and significantly reduced levels of protective antibody titers. While age-related decline in T cell function has been demonstrated and is being actively investigated, remarkably little is known about how aging affects Ag presenting cells (APC). These cells (especially dendritic cells (DC)) are critical for induction of both humoral and cell mediated immunity. Our preliminary data suggests abnormally elevated IFN-a and depressed IL-12 production by DC in geriatric individuals. This cytokine pattern may lead to a decline in T helper cell generation. In addition our data suggests that class II MHC (MHC-II) levels are reduced in DC in geriatric individuals. This could result in reduced Ag presentation by DC leading to suboptimal generation of CD4+ T helper cells.
It is our overall hypothesis that APC defects contribute to decreased T and B cell responses to influenza in geriatrics. A better understanding of specific defects in geriatric APC might allow a targeted approach to engineer vaccines for the elderly. We will approach this with the following specific aims:
Aim 1. To determine the specific defects in innate immune responses of DC to influenza in geriatric individuals. We will compare innate responses of plasmacytoid DC and myeloid DC to influenza in individuals aged >65 and those aged 21-35. Specifically, we will analyze DC for production of cytokines and chemokines, and maturation, costimulation, and homing markers after influenza stimulation. We will examine several potential mechanisms for the cytokine dysregulation in geriatric DC.
Aim 2. To determine if DC and B cells from geriatric individuals have a MHC class II defect in Ag processing and presentation of influenza. We will determine if MHC-II Ag processing and presentation of influenza in DC and B cells from elderly individuals is defective using HLA-DR matched T cell hybridomas. If defects are observed, mechanisms of the defects will be explored. Ag processing and presentation efficiency of B cells is important for them to receive optimal costimulation from CD4+ T helper cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients
-
批准号:10663064
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:DAVID H CANADAY
-
依托单位:
Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients
-
批准号:10426040
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:DAVID H CANADAY
-
依托单位:
Epidemiology, transmission and immunology of COVID-19 in nursing home residents
-
批准号:10326526
-
项目类别:
-
资助金额:$133.24万
-
财政年份:2020
-
负责人:DAVID H CANADAY
-
依托单位:
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care
-
批准号:9412645
-
项目类别:
-
资助金额:$79.99万
-
财政年份:2017
-
负责人:DAVID H CANADAY
-
依托单位:
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
-
批准号:8059671
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2010
-
负责人:DAVID H CANADAY
-
依托单位:
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
-
批准号:7840614
-
项目类别:
-
资助金额:$51.62万
-
财政年份:2010
-
负责人:DAVID H CANADAY
-
依托单位:
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
-
批准号:8239554
-
项目类别:
-
资助金额:$55.12万
-
财政年份:2010
-
负责人:DAVID H CANADAY
-
依托单位:
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
-
批准号:8435529
-
项目类别:
-
资助金额:$50.48万
-
财政年份:2010
-
负责人:DAVID H CANADAY
-
依托单位:
Predictors of Immunologic Failure in Older Adults
-
批准号:7908825
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID H CANADAY
-
依托单位:
Predictors of Immunologic Failure in Older Adults
-
批准号:8195966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID H CANADAY
-
依托单位:
Predictors of Immunologic Failure in Older Adults
-
批准号:7797075
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID H CANADAY
-
依托单位:
Mechanisms of MHC-II antigen processing of HIV in macrophages and dendritic cells
-
批准号:7337009
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2007
-
负责人:DAVID H CANADAY
-
依托单位:
Mechanisms of MHC-II antigen processing of HIV in macrophages and dendritic cells
-
批准号:7469545
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2007
-
负责人:DAVID H CANADAY
-
依托单位:
Dysfuntional antigen presenting cell responses to influenza in geriatric individu
-
批准号:7392578
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2007
-
负责人:DAVID H CANADAY
-
依托单位:
Antigen Processing in HIV-infected Individuals
-
批准号:6892745
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2005
-
负责人:DAVID H CANADAY
-
依托单位:
Antigen Processing in HIV-infected Individuals
-
批准号:7025922
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2005
-
负责人:DAVID H CANADAY
-
依托单位:
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS
-
批准号:6372624
-
项目类别:
-
资助金额:$12.04万
-
财政年份:1999
-
负责人:DAVID H CANADAY
-
依托单位:
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS
-
批准号:2731038
-
项目类别:
-
资助金额:$7.78万
-
财政年份:1999
-
负责人:DAVID H CANADAY
-
依托单位:
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS
-
批准号:6510020
-
项目类别:
-
资助金额:$12.04万
-
财政年份:1999
-
负责人:DAVID H CANADAY
-
依托单位:
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS
-
批准号:6168744
-
项目类别:
-
资助金额:$10.96万
-
财政年份:1999
-
负责人:DAVID H CANADAY
-
依托单位:
海外基金